This “From the Editor” in the Cleveland Clinic Journal of Medicine offers a nuanced view of corticosteroid therapy, highlighting the balance between their significant therapeutic benefits and the risk of adverse effects in long-term use.

Acquired reactive perforating collagenosis, characterized by pruritic eruptions and systemic associations, often manifests in patients with diabetes or chronic kidney disease, underscoring the necessity for holistic patient assessment in dermatological evaluations.

Managing venous thromboembolism effectively demands a nuanced understanding of updated clinical guidelines, which now differentiate treatment protocols based on specific risk assessments and patient comorbidities.

Microscopic colitis, often masked in routine diagnostic evaluations, necessitates a histological approach for accurate diagnosis. The disease’s association with specific medications underscores the need for careful patient medication reviews.

In a recent case, symptomatic joint pain and distinctive physical signs in a patient led to the identification of non-small-cell lung cancer, highlighting the critical role of thorough clinical assessment in revealing potential underlying malignancies.

Explore the potential of Rejoyn™, a digital therapeutic now cleared by the FDA, which has shown to significantly reduce depressive symptoms in adults as an adjunct to traditional outpatient care, without any reported adverse events.